Anand P. V. V. M, Kranthi K, Punnagai K, David D. C. Evaluation of Alpha-Glucosidase Inhibitory Activity of Vinca Rosea. Biomed Pharmacol J 2019;12(2).

---

Manuscript received on :16-Apr-2019
Manuscript accepted on :18-June-2019
Published online on: 28-06-2019

---

Plagiarism Check: Yes
Reviewed by: Hendry Irawan
Second Review by: Sadegh Rajabi

How to Citeclose    |   Publication History close

 Views: (Visited 1,260 times, 1 visits today)    PDF Downloads: 680

Anand Priya V. V. M, K. Kranthi, K. Punnagai and Darling Chellathai David

Department of Pharmacology, Sri Ramachandra Medical College and Research Institute, SRIHER, Porur, Chennai, India.

Corresponding author E-mail: drkranthi10@gmail.com

DOI : https://dx.doi.org/10.13005/bpj/1700

Abstract

Diabetes mellitus (DM) has developed into serious health problem worldwide. α-glucosidase inhibitors are used in management of  Type II Diabetes mellitus. Medicinal plants are known to be effective in treating various diseases and disorders. Catharanthus roseus belonging to family Apocyanaceae is very well known for its anticancer property. The present study was aimed to compare the alpha glucosidase inhibitory effect of leaves and flowers extracts of Vinca rosea by an in-vitro assay. Methanolic extracts were obtained using Soxhlet apparatus. Yeast alpha glucosidase was used as the enzyme source. Acarbose was used as the reference drug. The % inhibition was calculated. The results proved that both leaves and flowers extract of Vinca rosea possess α-glucosidase inhibitor activity. The leaf extract (57.87%) showed a better activity when compared to flower extracts (48.31%). The result supports Vinca rosea as a potential source in treating Diabetes mellitus.

Keywords

α-Glucosidase; Acarbose; Anticancer; Apocyanaceae; Catharanthus Roseus; Diabetes Mellitus

Introduction

Diabetes mellitus (DM) is one of the major health issues worldwide and its increasing trend is expected to be doubled by 2030.¹ International Diabetes Federation (IDF), states that the prevalence of diabetes mellitus is more common among developing countries where people take high-calorie food in their diets and lack of physical exercises.¹ The onset of diabetes mellitus differs from individual to individual, but middle aged and adults are always at higher risk. Type II Diabetes mellitus is more common and exhibits approximately 90%–95% of all cases.² Type II diabetes mellitus is caused by the decreased production of insulin by the pancreatic β-cells or due to excessive assimilation of glucose which leads to insulin resistance resulting in hyperglycaemia.^3,4 Chronic hyperglycaemia can lead to several microvascular and macrovascular complications.

𝛼-glucosidase is an enzyme which is responsible for the conversion of complex carbohydrates into glucose. This enzyme acts by delaying the breakdown of complex carbohydrates into glucose and reduces its absorption rate from the gut which results in reduction of postprandial blood sugar level.⁵ This therapeutic approach has been recommended by the Third Asia-Pacific Region Diabetes Treatment Guidelines as the first-line of treatment for lowering postprandial hyperglycaemia.⁶

Although commercially available α-glucosidase inhibitors like Voglibose and Acarbose are used effectively in controlling blood glucose levels, they have been associated with serious gastrointestinal side effects. Therefore, there is a need to search for an alternative that can exhibit α-glucosidase inhibitory activity without side effects.⁷

Medicinal plants have been used since ages to treatment various ailments. Vinca rosea (C. roseus) Linn, commonly known as Madagascar periwinkle is a flowering herb that belongs to Apocynaceae family. They contain dimeric alkaloids, vinacristine and vinblastine that are used as anticancer drugs, while roots have ajmalicine and serpentine which is used to treat hypertension.⁸ The leaves are used traditionally to control diabetes worldwide, including India. Earlier studies on laboratory animals have reported that the leaf extracts possess a very good antihyperglycemic and hypotensive activity. Leaf juice of the plant was noted to reduce blood glucose in alloxan induced diabetic rabbits. Leaves and twigs have been reported to reduce blood glucose level  in alloxan induced diabetic rats.⁹ Apart from this the plant is also used in treating malaria and sore throat. Literature shows that these plants are used in the regulation of menstrual cycles and as euphoriant.¹⁰

The present study was aimed to compare the alpha glucosidase inhibitory activity of methanolic extract of leaves and flowers of Catharanthus roseus.

Materials and Methods

Chemicals
α-glucosidase was purchased from Sigma-Aldrich, Bangalore.

Plant Materials

The plant parts were identified and authenticated by Department of Botany, National Institute of Siddha-Chennai.

Extraction of Plant Material¹¹

The Leaves and flowers were removed separately, air dried under shade, powdered and stored in an airtight container. The powdered material was extracted with methanol (80%) by the process of soxhlation. The filtrate was concentrated at reduced pressure by rotary flash vacuum evaporator.

Determination of yeast alpha-glucosidase inhibitor activity¹²

The yeast alpha glucosidase was dissolved in 100 mM phosphate buffer pH 6.8 and was used as the enzyme source. P-Nitrophenyl-α-D-glucopyranoside was used as the substrate. Acarbose was used as the Standard drug for alpha glucosidase inhibitor. Plant extracts were used in the concentration ranging from 20-200 µg/ml. Different concentrations of leaf and flower extracts of Vinca rosea and Acarbose (0.025, 0.05, 0.1, 0.15, 0.2 mg/ml) was mixed with 320 µl of 100 mM phosphate buffer. The mixture was incubated  at 30 °C for 5 minutes. 3 ml of 50 mM sodium hydroxide was added to the mixture and the absorbance was read at 410 nm using spectrophotometer. The control samples were prepared without adding any plant extracts. The % inhibition was calculated according to the formula.

Results and Discussion

Diabetes mellitus is a well-known metabolic disorder, which is characterized by an elevated blood glucose level. The reason for this condition is either due to the loss of production of insulin by the pancreas or reduced response by the cells to the produced insulin or both. Controlling the postprandial hyperglycaemia is of prime importance in management of Type II Diabetes mellitus. α-Glucosidase plays a vital role in digestion of complex carbohydrate to glucose, hence its inhibition is considered as one of the targets for managing postprandial hyperglycaemia. Acarbose has α-glucosidase and α-amylase inhibitory activity but known to cause  side effects such as bloating, flatulence and diarrhoea.¹³

The use of herbal drugs in treating Diabetes mellitus and its complications is growing globally. In the present study, inhibitory activity of methanolic extracts of leaves and flowers of Vinca rosea on yeast alpha glucosidase was investigated. The results are given in Table 1. Percentage of α-Glucosidase inhibition by the leaves and flowers extract were plotted as a function of concentration in comparison with Acarbose (Fig.1). All the extracts showed a concentration-dependent inhibition of α-glucosidase. The standard drug Acarbose showed highest α-glucosidase inhibition (62.36%) followed by leaf (57.87%) and flower (48.31%) extract   respectively at their highest concentrations tested.

Table 1: α-glucosidase inhibitory effects of methanolic extract of leaves and flowers of Vinca rosea and Acarbose.

Figure 1: Percentage α-glucosidase inhibitory effects of methanolic extract of leaves and flowers of Vinca rosea and Acarbose.   Click here to view figure

Conclusion

The results of the present study showed that methanolic leaves and flowers extract of Vinca rosea possess α-glucosidase inhibitor activity which may be useful in management of Type II Diabetes mellitus. The leaves extract showed a better activity when compared to flowers extract. However these effects need to be confirmed by testing these extracts of Vinca rosea in different in– vivo models before developing into a new antidiabetic agents.

Conflict of Interest

There are no conflicts of interest.

References

1. International Diabetes Federation (IDF). Diabetes Atlas. 5th ed. Brussels, Belgium: International Diabetes Federation; 2011.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care.2004; 27:1047-53.
3. Ardisson Korat AV, Willett WC, Hu FB. Diet, lifestyle, and genetic risk factors for type 2 diabetes: A review from the Nurses’ Health Study, Nurses’ Health Study 2, and Health Professionals’ Follow-up Study. Curr Nutr Rep. 2014; 3:345-54.
4. Patti ME, Corvera S. The role of mitochondria in the pathogenesis of type 2 diabetes. Endocr Rev. 2010; 31:364-95.
5. Subramanian R, Asmawi AZ, Sadikun A, J Pol Biochem Soc.2008, 55:391-398.
6. P. Li, B. Bai, J. Ye, et al., Reviews on preparation and determination of α-glucosidase inhibitor, Food Sci. 29:2008; 617–619.
7. Playford RJ, Pither C, Gao R, Middleton SJ. Use of the alpha glucosidase inhibitor acarbose in patients with ‘Middleton syndrome’: normal gastric anatomy but with accelerated gastric emptying causing postprandial reactive hypoglycemia and diarrhea. Can J Gastroenterol. 2013;27(7):403-4.
8. Jaleel, C.A., R. Gopi, G.M.A. Lakshmanan and R. Panneerselvam. Triadimefon induced changes in the antioxidant metabolism and ajmalicine production in Catharanthus roseus(L.) G. Don. Plant Sci.2006; 171: 271-276.
9. Jayanthi M,  Sowbala  N,  Rajalakshmi  G,  Kanagavalli  U, Sivakumar    Study  of  anti-hyperglycemic  effect  of  Catharanthus  roseus  in  alloxan-induced  diabetic  rats.  Int  J Pharm Pharm Sci. 2010; 2:114-116.
10. Bhutkar MA, Bhise SB. Comparative studies on antioxidant properties of Catharanthus rosea and Catharanthus alba. Int J Pharm Tech Res., 2011; 3(3):1551-1556.
11. Khandelwal KR. Practical Pharmacognosy: Techniques and Experiments, Nirali Prakashan, Pune. 2005, 149-53.
12. Jung M, Park M, Chul HL, Kang Y, Seok-Kang E, Ki-Kim S. Antidiabetic agents from medicinal plants. Curr Med Chem. 2006;13:1–16.
13. Vichayanrat A, Ploybutr S, Tunlakit M, Watanakejorn P. Efficacy and safety of voglibose in comparison with acarbose in type 2 diabetic patients. Diabetes Res Clin Pract. 2002;55:99–103.